Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has spread to more than 70 countries worldwide since 2015. Despite active research, there are currently no licensed vaccines or therapeutics. We have previously reported the development of various adenoviral vectored vaccine candidates...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	López-Camacho, C, Kim, Y, Abbink, P, Larocca, R, Huiskonen, J, Barouch, D, Reyes-Sandoval, A
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	MDPI 2019

Ижил төстэй зүйлс

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
-н: César López-Camacho, зэрэг
Хэвлэсэн: (2019-11-01)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
-н: Moorthy, V, зэрэг
Хэвлэсэн: (2003)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
-н: Alharbi, N
Хэвлэсэн: (2014)

Clinical development of Modified Vaccinia virus Ankara vaccines.
-н: Gilbert, S
Хэвлэсэн: (2013)

Clinical development of Modified Vaccinia virus Ankara vaccines
-н: Gilbert, S
Хэвлэсэн: (2013)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
-н: McConkey, S, зэрэг
Хэвлэсэн: (2003)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
-н: Rosario, M, зэрэг
Хэвлэсэн: (2010)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
-н: Schneider, J, зэрэг
Хэвлэсэн: (1998)

Safety and immunogenicity of IMVAMUNE®, a third-generation vaccine based on the modified vaccinia Ankara (MVA) strain
-н: L. F. Stovba, зэрэг
Хэвлэсэн: (2023-04-01)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
-н: Olga Vladimirovna Orlova, зэрэг
Хэвлэсэн: (2022-09-01)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
-н: Nereida Jiménez de Oya, зэрэг
Хэвлэсэн: (2022-03-01)

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
-н: López-Camacho, C, зэрэг
Хэвлэсэн: (2020)

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity
-н: Alharbi, N, зэрэг
Хэвлэсэн: (2015)

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.
-н: Naif Khalaf Alharbi, зэрэг
Хэвлэсэн: (2015-01-01)

Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
-н: Lior Nave, зэрэг
Хэвлэсэн: (2023-08-01)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
-н: Kaïdre Bendjama, зэрэг
Хэвлэсэн: (2017-09-01)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
-н: Goepfert P, зэрэг
Хэвлэсэн: (2012-09-01)

Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia Ankara-vectored Ebola vaccines: a randomized clinical trial
-н: Milligan, I, зэрэг
Хэвлэсэн: (2016)

Immunogenicity and reactogenicity of novel adenovirus type 26 and modified vaccinia Ankara-vectored Ebola vaccines: A randomized clinical trial
-н: Milligan, I, зэрэг
Хэвлэсэн: (2016)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
-н: Mcshane, H, зэрэг
Хэвлэсэн: (2001)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
-н: Behboudi, S, зэрэг
Хэвлэсэн: (2004)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
-н: César López-Camacho, зэрэг
Хэвлэсэн: (2020-06-01)

Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
-н: Valentina Mazzotta, зэрэг
Хэвлэсэн: (2024-12-01)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
-н: Goonetilleke, N, зэрэг
Хэвлэсэн: (2003)

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
-н: Mingwang Shen, зэрэг
Хэвлэсэн: (2024-10-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
-н: Gilbert, S, зэрэг
Хэвлэсэн: (1999)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
-н: Juan García-Arriaza, зэрэг
Хэвлэсэн: (2021-08-01)

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.
-н: Jeffrey R Currier, зэрэг
Хэвлэсэн: (2010-11-01)

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.
-н: Sandhya Vasan, зэрэг
Хэвлэсэн: (2010-01-01)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
-н: Hanke, T, зэрэг
Хэвлэсэн: (1998)

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects.
-н: Howles, S, зэрэг
Хэвлэсэн: (2010)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
-н: Caroline Staib, зэрэг
Хэвлэсэн: (2003-04-01)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
-н: Volker Sandig, зэрэг
Хэвлэсэн: (2013-11-01)

Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates
-н: Leonie Mayer, зэрэг
Хэвлэсэн: (2024-11-01)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
-н: Flavia Chiuppesi, зэрэг
Хэвлэсэн: (2024-02-01)

The Efficacy of Disinfection on Modified Vaccinia Ankara and African Swine Fever Virus in Various Forest Soil Types
-н: Franziska Tanneberger, зэрэг
Хэвлэсэн: (2021-10-01)

Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine
-н: Harriet L. Robinson, зэрэг
Хэвлэсэн: (2018-09-01)

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
-н: David A Garber, зэрэг
Хэвлэсэн: (2009-01-01)

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates
-н: Leonie Mayer, зэрэг
Хэвлэсэн: (2024-12-01)

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
-н: C. Staib, зэрэг
Хэвлэсэн: (2000-06-01)